Picture of Alpine Immune Sciences logo

ALPN — Alpine Immune Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Alpine Immune Sciences Inc reports results for the quarter ended in January - Earnings Summary

* Alpine Immune Sciences Inc  ALPN.OQ  reported a quarterly
adjusted loss of 28 cents​​ per share for the quarter ended in
January, identical to the same quarter last year.  The mean
expectation of seven analysts for the quarter was for a loss
of 41 cents per share. Wall Street expected results to range
from -51 cents to -29 cents per share.
    * Revenue fell 25.1% to $7.03 million from a year ago;
analysts
expected $3.52 million. 
    * Alpine Immune Sciences Inc's reported EPS for the quarter
was a
loss of 28 cents​.
    * The company reported a quarterly loss of $17.92 million.
    * Alpine Immune Sciences Inc shares had risen by 63.2% this
quarter and gained 239.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 15.7%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Alpine Immune
Sciences Inc is $65.00 
This summary was machine generated from LSEG data May 9 at 09:35
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.41          -0.28          Beat
 Dec. 31 2023      -0.34          0.12           Beat
 Sep. 30 2023      -0.33          -0.24          Beat
 Jun. 30 2023      -0.37          -0.27          Beat

Recent news on Alpine Immune Sciences

See all news